Literature DB >> 4037775

In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sobria, and Aeromonas caviae to 22 antimicrobial agents.

M R Motyl, G McKinley, J M Janda.   

Abstract

MICs of 22 antimicrobial agents for 60 strains of three Aeromonas species were determined by a microdilution method. The newer cephalosporins such as moxalactam, cefotaxime, and cefoperazone, the aminoglycosides, and chloramphenicol, tetracycline, nitrofurantoin, and trimethoprim-sulfamethoxazole inhibited most of the strains studied. Within the genus, A. hydrophila was more resistant than either A. caviae or A. sobria to the antibiotics tested.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4037775      PMCID： PMC176330          DOI： 10.1128/AAC.28.1.151

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  A taxonomic study of the Aeromonas hydrophila-Aeromonas punctata group.

Authors:  M Popoff; M Véron
Journal:  J Gen Microbiol       Date:  1976-05

2.  In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

3.  Isolation of drug-resistant Aeromonas hydrophila from aquatic environments.

Authors:  L A McNicol; K M Aziz; I Huq; J B Kaper; H A Lockman; E F Remmers; W M Spira; M J Voll; R R Colwell
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

4.  In vitro susceptibilities of Aeromonas hydrophila against new antibiotics.

Authors:  V Fainstein; S Weaver; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

5.  Antimicrobial susceptibility of Aeromonas hydrophila.

Authors:  T L Overman
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

6.  Association of Aeromonas sobria with human infection.

Authors:  O P Daily; S W Joseph; J C Coolbaugh; R I Walker; B R Merrell; D M Rollins; R J Seidler; R R Colwell; C R Lissner
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

Review 7.  Human aeromonas infections: a review of the literature and a case report of endocarditis.

Authors:  W A Davis; J G Kane; V F Garagusi
Journal:  Medicine (Baltimore)       Date:  1978-05       Impact factor: 1.889

8.  Correlation of enterotoxicity with biotype in Aeromonas spp.

Authors:  V Burke; J Robinson; J Beaman; M Gracey; M Lesmana; R Rockhill; P Echeverria; J M Janda
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

9.  Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum.

Authors:  J M Janda; M Reitano; E J Bottone
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

10.  Cholera-like illness due to Aeromonas sobria.

Authors:  H Champsaur; A Adremont; D Mathieu; E Rottman; P Auzepy
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226
View more
  31 in total

1.  Antimicrobial susceptibilities of Aeromonas strains isolated from clinical and environmental sources to 26 antimicrobial agents.

Authors:  Max Aravena-Román; Timothy J J Inglis; Barbara Henderson; Thomas V Riley; Barbara J Chang
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

Review 2.  Recent advances in the study of the taxonomy, pathogenicity, and infectious syndromes associated with the genus Aeromonas.

Authors:  J M Janda
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

3.  In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan.

Authors:  Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

4.  Evaluation of the Sceptor system for identification of bacteria of veterinary origin.

Authors:  J R Papp; C A Muckle
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

5.  Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan.

Authors:  W C Ko; K W Yu; C Y Liu; C T Huang; H S Leu; Y C Chuang
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

6.  Which antibiotics and breakpoints should be used for Aeromonas susceptibility testing? Considerations from a comparison of agar dilution and disk diffusion methods using Enterobacteriaceae breakpoints.

Authors:  B Lamy; F Laurent; A Kodjo; F Roger; E Jumas-Bilak; H Marchandin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-27       Impact factor: 3.267

7.  Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.

Authors:  J S Bakken; C C Sanders; R B Clark; M Hori
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

8.  Cephalothin susceptibility as a potential marker for the Aeromonas sobria group.

Authors:  J M Janda; M R Motyl
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

9.  Antimicrobial susceptibility patterns of Aeromonas jandaei, A. schubertii, A. trota, and A. veronii biotype veronii.

Authors:  T L Overman; J M Janda
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  beta-Lactam resistance of motile Aeromonas isolates from clinical and environmental sources.

Authors:  K Morita; N Watanabe; S Kurata; M Kanamori
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.